Evidence Dose
← All articles Supplements

Is Creatine Bad for Your Kidneys? What Studies Actually Show

Dr Cath
Chemistry PhD · evidence-based supplementation

This post contains affiliate links. If you click a link and make a purchase, I may earn a small commission at no extra cost to you.

Is Creatine Bad for Your Kidneys? What Studies Actually Show

For a healthy adult with normal kidney function, the mainstream research on creatine has not found evidence that ordinary supplemental doses damage the kidneys. That is the direction of the answer. But the answer has edges, and most of the confusion on this topic comes from a single laboratory number that behaves in a way that looks alarming and means almost nothing.

This piece is not about whether creatine works. It is about whether it harms the kidneys, from what dose, in whom, and where the honest gaps in the evidence sit. Let me be clear about what I can and cannot say from the evidence, because the two halves of this topic are not equally settled.

Why does the creatinine number scare people?

Almost the entire worry about creatine and kidneys rests on a laboratory misunderstanding, so it belongs first.

Creatine and creatinine are not the same molecule, and this is the single most important distinction on the page. Creatine is the compound you supplement. Creatinine is its breakdown product — the waste form your muscles produce continuously and your kidneys clear. Doctors measure serum creatinine as a proxy for kidney filtration: if the kidneys are struggling, creatinine backs up in the blood.

Here is the problem. When you take supplemental creatine and carry more of it in your muscles, you produce more creatinine as a normal metabolic consequence. Your serum creatinine can rise without your kidneys doing anything wrong at all. The proxy moves, but the thing the proxy is meant to estimate has not changed.

This is a textbook example of a biomarker shifting for a reason that has nothing to do with the outcome it usually signals. A raised creatinine in a creatine user is a mechanism-level fact about creatine metabolism, not evidence of kidney injury. If a routine blood test flags it, that context matters — mention your supplement use to whoever ordered the test, because the number can be misread as declining kidney function when it is nothing of the kind.

Two takeaways from this section, kept separate because they are different claims:

  • A rise in serum creatinine in a creatine user is expected and does not, on its own, indicate harm.
  • Estimated glomerular filtration rate (eGFR) equations built on creatinine can therefore underestimate true filtration in creatine users — again, an artefact, not damage.

What sets the real ceiling on creatine intake?

In a healthy adult, the practical upper limit on creatine is set by gut tolerance long before it is set by anything to do with the kidneys.

The most common dose-dependent effect is gastrointestinal: an osmotic effect in the gut when a large amount is taken at once, particularly during a high-dose loading approach where several grams are consumed in a single sitting. The recognisable symptoms are stomach discomfort, bloating, and a laxative effect. They are dose- and timing-dependent, they resolve when the amount per serving is reduced or spread across the day, and they resolve on their own once the dose comes down. That is your cheapest test that you have exceeded your own tolerance, and it costs nothing to run.

Water retention inside muscle tissue is also commonly reported early in use. This is expected physiology from how creatine draws water into muscle cells, not a sign of a kidney or fluid-handling problem.

None of these effects is a kidney safety signal. They are comfort and dosing considerations.

Who should not treat creatine as automatically safe?

This is the section that actually matters for a safety decision, and it is short by design.

The reassurance above applies to people with normal kidney function. It does not automatically extend to someone with existing kidney disease, reduced renal function, or a single kidney. In that setting the calculus is different: the kidney has less reserve, and the whole point of monitoring creatinine is to track a system that is already compromised. Whether creatine is appropriate there is a clinical judgement, not a general-audience one, and it is a judgement that should be made before starting rather than after a worrying lab result. This is information you are entitled to have going into that conversation — not a reason to skip it.

Two further groups belong in a decisions category rather than a prohibition:

  • Pregnancy and breastfeeding. This is not a population where the safety of supplementation has been well characterised, so the decision belongs with a clinician.
  • People taking medications that affect kidney function or are cleared by the kidneys. Here the honest statement is about the limits of what is known: the concern is mechanistic — added load or interacting clearance — rather than a specific, clinically demonstrated interaction reported in the literature. That distinction changes how much weight to give it, but it is a legitimate reason to raise the question if it applies to you.

What does "well tolerated" actually claim here?

Creatine is one of the more heavily studied sports supplements, and in healthy participants it is generally described as well tolerated. It is worth being precise about what that phrase does and does not cover.

"Well tolerated" describes what happened to participants — typically healthy adults, often studied over defined and frequently short periods. It is not the same statement as "safe for everyone, indefinitely, at any dose." Two specific gaps follow from that:

  • The reassurance is strongest for the populations and durations that were studied. Very long-term use across decades, and use in people the trials excluded, is less characterised.
  • Absence of harm reports is not the same as demonstrated safety, especially for supplements, where adverse events are not collected systematically the way they are for prescription medicines. "Not shown to cause harm" and "shown to be harmless" are different tiers of evidence, and the honest position sits on the first.

Two pooled analyses put numbers on the gap. A 2026 meta-analysis of 19 randomised controlled trials found creatine raised serum creatinine by about 0.13 mg/dL on average, while blood urea and estimated GFR were no different from control; its authors note that trials running beyond a year still do not exist, which is the honest limit on how far the reassurance stretches. A 2025 systematic review across 21 studies found the same shape — a small, statistically significant rise in creatinine, no significant change in GFR — and read it as metabolic turnover rather than impaired filtration. The doses described as well tolerated in this literature are the ordinary ones: roughly 3–5 g a day, or 0.1 g per kilogram of body mass.

That said, the specific fear this article addresses — that ordinary creatine use damages healthy kidneys — is not supported by the human research, and the evidence would have changed clinical practice if it were. The gap between mechanism-level worry (a moving biomarker) and a demonstrated outcome (actual kidney injury) is the whole story here.

Does the form of creatine change the kidney question?

No. The kidney question is about the compound, not the packaging.

Various marketed forms — different physical presentations and branded variants — are still creatine. A capsule versus a powder is a delivery-format choice about convenience and dosing precision, not a different safety profile for the kidneys. Where you have a choice, the sensible default is the plainest, most-studied form, and the two things worth checking on any label are an ingredient list you can read and evidence of third-party batch testing — neither of which a novel form promising an unproven advantage supplies. A capsule format such as Creatine Capsules sits in that plain-monohydrate category; whether it meets those two checks is something you read off the label, and either way the format changes none of the safety reasoning above.

Verdict: what to watch for and what to do about it

If you have normal kidney function, the human evidence does not support the idea that standard creatine use harms your kidneys, and a rise in serum creatinine on a routine test is most likely a metabolic artefact rather than a warning.

Two operational branches, because they call for different actions:

  • Reduce the dose and carry on: stomach discomfort, bloating, or a laxative effect after a large single serving. Spread the amount across the day or lower it; these are tolerance signals, not kidney signals.
  • Pause and seek advice first: if you have known kidney disease, reduced renal function, a single kidney, are pregnant or breastfeeding, or take medication that affects kidney clearance. Here the decision is a clinician's, and it is worth making before you start rather than in response to a lab number.

The one thing to carry away: creatine and creatinine are different molecules, and a moving creatinine number in a healthy creatine user tells you about creatine metabolism, not about kidney damage. Do not let a proxy measurement, misread, decide something the proxy was never measuring.

Sources

Recommended

Prices and availability are pulled live; this section contains affiliate links.

Popular articles


Content on this site is for informational and educational purposes only and is not medical advice. Consult a physician or pharmacist before starting any supplementation.

Contents